I. Bodrogi

16.5k citations
79 papers · 10.4k · 4 hit papers · h-index 21

Impact in

Papers in

I. Bodrogi

69 papers receiving 10.2k citations

I. Bodrogi's Hit Papers

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial 2010 · 2.4k citations
2.4k0+8+17Years since publication50010001.5k2.0k2.5k

Peers

I. Bodrogi
Comparison fields: 5 of 106
  • Pulmonary and Respiratory Medicine 5.5k
  • Cancer Research 2.1k
  • Oncology 2.5k
  • Surgery 2.1k
  • Molecular Biology 3.2k
Replace Christine Théodore with:
Christine Théodore France
Gary R. Hudes United States
Gwénaëlle Gravis France
Peter F.A. Mulders Netherlands
Aude Fléchon France
Sergio Bracarda Italy
Ronald B. Natale United States
M. Dror Michaelson United States
Carsten Goessl United States
Christine Chevreau France
I. Bodrogi relative to Christine Théodore France Christine Théodore's profile →
Citations per field
00.5×1.5×2.0×
Christine Théodore · 1×
Citations per year

Countries citing papers authored by I. Bodrogi

Since Specialization
Citations

This map shows the geographic impact of I. Bodrogi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Bodrogi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Bodrogi more than expected).

Fields of papers citing papers by I. Bodrogi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Bodrogi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Bodrogi. The network helps show where I. Bodrogi may publish in the future.

Co-authors

The 25 scholars most cited alongside I. Bodrogi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I. Bodrogi Line = papers co-authored together I. Bodrogi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Hit paper breakdown →
20072825
2
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Hit paper breakdown →
20102417
3
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
Hit paper breakdown →
20071725
4
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
Hit paper breakdown →
20001701
5 2009266
6 2007233
7 1998205
8 2004121
9 1998120
10 1998101
11 200879
12 201168
13 200939
14 200438
15 200636
16 200334
17
Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors.
200631
18 200424
19 200423
20 202321

About I. Bodrogi

I. Bodrogi is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Cancer Research, having authored 79 papers that have together received 10.4k indexed citations. Recurring topics across this work include Testicular diseases and treatments (25 papers), Renal cell carcinoma treatment (8 papers), Prostate Cancer Treatment and Research (7 papers), Cancer Treatment and Pharmacology (6 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer therapeutics and mechanisms (5 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Renal and related cancers (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.5k citations), Cancer Research (2.1k citations), Oncology (2.5k citations), Surgery (2.1k citations) and Molecular Biology (3.2k citations). I. Bodrogi has collaborated with scholars based in Hungary, France and United States. Frequent co-authors include Oliver Sartor, Stéphane Oudard, Mustafa Özgüroğlu, Gwénaëlle Gravis, Ivo Kocák, Liji Shen, Steinbjørn Hansen, Johann S. de Bono, Mary J. MacKenzie and Jean-Pascal Machiels. Their work appears in journals such as Journal of Clinical Oncology, Oncology, Annals of Oncology, European Journal of Cancer and Pathology & Oncology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact